J
Julie von Ziegenweidt
Researcher at Norwich University
Publications - 33
Citations - 1702
Julie von Ziegenweidt is an academic researcher from Norwich University. The author has contributed to research in topics: Asthma & Retrospective cohort study. The author has an hindex of 19, co-authored 31 publications receiving 1545 citations. Previous affiliations of Julie von Ziegenweidt include University of Cambridge.
Papers
More filters
Journal ArticleDOI
The Human Phenotype Ontology in 2017
Sebastian Köhler,Nicole Vasilevsky,Mark Engelstad,Erin D. Foster,Julie A. McMurry,Ségolène Aymé,Gareth Baynam,Gareth Baynam,Susan M. Bello,Cornelius F. Boerkoel,Kym M. Boycott,Michael Brudno,Orion J. Buske,Patrick F. Chinnery,Valentina Cipriani,Laureen E. Connell,Hugh Dawkins,Laura E. DeMare,Andrew D. Devereau,Bert B.A. de Vries,Helen V. Firth,Kathleen Freson,Daniel Greene,Ada Hamosh,Ingo Helbig,Ingo Helbig,Courtney Hum,Johanna A. Jähn,Roger James,Roland Krause,Stanley J. F. Laulederkind,Hanns Lochmüller,Gholson J. Lyon,Soichi Ogishima,Annie Olry,Willem H. Ouwehand,Nikolas Pontikos,Ana Rath,Franz Schaefer,Richard H. Scott,Michael M. Segal,Panagiotis I. Sergouniotis,Richard Sever,Cynthia L. Smith,Volker Straub,Rachel Thompson,C. Turner,Ernest Turro,Marijcke W. M. Veltman,Tom Vulliamy,Jing Yu,Julie von Ziegenweidt,Andreas Zankl,Stephan Züchner,Tomasz Zemojtel,Julius O.B. Jacobsen,Tudor Groza,Damian Smedley,Christopher J. Mungall,Melissa A. Haendel,Peter N. Robinson +60 more
TL;DR: The progress of the HPO project is reviewed, including specific areas of expansion such as common (complex) disease, new algorithms for phenotype driven genomic discovery and diagnostics, integration of cross-species mapping efforts with the Mammalian Phenotype Ontology, an improved quality control pipeline, and the addition of patient-friendly terminology.
Journal ArticleDOI
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort
Rupert Jones,David Price,Dermot Ryan,Dermot Ryan,Erika J. Sims,Julie von Ziegenweidt,Laurence Mascarenhas,Anne Burden,David M.G. Halpin,Robert Winter,Sue Hill,Matt Kearney,Kevin Holton,Anne Moger,Daryl Freeman,Alison Chisholm,Eric D. Bateman +16 more
TL;DR: Opportunities to diagnose COPD at an earlier stage are being missed, and could be improved by case-finding in patients with lower respiratory tract symptoms and concordant long-term comorbidities.
Journal ArticleDOI
Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control
Mike Thomas,David Price,Henry Chrystyn,Andrew Lloyd,Angela E. Williams,Julie von Ziegenweidt +5 more
TL;DR: Switching ICS devices without a consultation was associated with worsened asthma control and is therefore inadvisable.
Journal ArticleDOI
Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: A real-world observational study
David Price,David Price,Richard J. Martin,Neil Barnes,Paul Dorinsky,Elliot Israel,Nicolas Roche,Alison Chisholm,Elizabeth V. Hillyer,Linda Kemp,Amanda J Lee,Julie von Ziegenweidt,Gene L. Colice +12 more
TL;DR: In a real-world setting patients receiving HFA-beclomethasone had a similar or better chance of achieving asthma control at lower prescribed doses than with fluticasone.
Journal ArticleDOI
Device type and real-world effectiveness of asthma combination therapy: An observational study
David Price,Nicolas Roche,J. Christian Virchow,Annie Burden,Muzammil Ali,Alison Chisholm,Amanda J Lee,Elizabeth V. Hillyer,Julie von Ziegenweidt +8 more
TL;DR: For UK primary care patients, pMDIs appear to achieve better asthma control outcomes than DPIs for delivery of FDC fluticasone-salmeterol.